Publications & Abstracts
Impact of Proximal Intestinal Exclusion with EndoBarrier on Key Metabolic Parameters and Cardiovascular Risk in the First NHS-UK EndoBarrier Service
In addition to reducing the requirement for insulin and a liver fat biomarker, EndoBarrier treatment reduced 10-year CVD risk by clinically useful...
EndoBarrier®: A Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes
Obesity associated with diabetes mellitus is a significant worldwide problem associated with considerable health care costs. Whilst surgical...
Comparative Efficacy and Safety of the Duodenal-Jejunal Bypass Liner in Obese Patients with Type 2 Diabetes Mellitus: A Case Control Study
This study provides the largest, so far, hypothesis-generating evidence for a putative positive risk/benefit ratio for treatment of obese patients...
EndoBarrier in Type 2 Diabetes/Pre-Diabetes with Obstructive Sleep Apnoea Study- Preliminary Results
End-OSA trial (ISRCTN:33788132) is an NIHR sponsored research trial, to assess the extent to which patients with type 2 diabetes/pre-diabetes,...
UK 1st National Health Service (NHS) EndoBarrier Service: Outcomes in 1st 38 Patients to Reach 6 Months after Device Explant
Our data demonstrate EndoBarrier as highly effective in patients with refractory diabesity. Maintenance of improvement after EndoBarrier removal was...
First Risk-Benefit Data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry
The effects of EndoBarrier therapy on glycaemic control, weight and blood pressure are likely to reduce the complications of type 2 diabetes. This...
Cost-Effectiveness Analysis of the EndoBarrier Device in Patients with Type 2 Diabetes
There are multiple pharmacotherapy options for type 2 diabetes mellitus (T2DM) including injectable glucagon-like peptide 1 receptor agonists...
EndoBarrier as a Pre Bariatric Surgical Intervention in High-Risk Patients: a Feasibility Study
Endoscopically placed duodenal-jejunal bypass sleeve (EndoBarrier) has been designed to achieve weight loss and improve glycaemic control in...
Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes
A total of 1,064 studies were identified, 147 of which were duplicates. After abstract review, 741 studies were excluded, leaving 176 articles for...
Efforts to Resurrect EndoBarrier for Use in Obese With Diabetes
Medscape article by author Marlene Busko.
Videos
How EndoBarrier Works
EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
Maintenance of Efficacy after EndoBarrier
UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
BBC News Item
EndoBarrier treatment for diabetes & obesity following 1 year results …
